Tertomotide
Tertomotide Uses, Dosage, Side Effects, Food Interaction and all others data.
Tertomotide is under investigation in clinical trial NCT01223209 (A Study, Combination, Immunologic Study of LTX-315 as adjunct to tertomotide in Patients Following Curative Surgery for Carcinoma). It is a peptide vaccine that activates the immune system so that it recognizes and kills cancer cells. It is being developed by Pharmexa A/S.
Tertomotide is a peptide vaccine that activates the immune system so that it recognises and kills cancer cells.
| Trade Name | Tertomotide |
| Generic | Tertomotide |
| Tertomotide Other Names | Tertomotide |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Tertomotide works
Tertomotide targets an enzyme called telomerase. Telomerase is seldom found in normal cell types but is overexpressed in most cancer cells.
Innovators Monograph
You find simplified version here Tertomotide
